| Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer C Denkert, S Loibl, A Noske, M Roller, BM Müller, M Komor, J Budczies, ... Journal of clinical oncology 28 (1), 105-113, 2010 | 1990 | 2010 |
| Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ... Nature biotechnology 31 (6), 539-544, 2013 | 1199 | 2013 |
| The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer A Afshar-Oromieh, E Avtzi, FL Giesel, T Holland-Letz, HG Linhart, M Eder, ... European journal of nuclear medicine and molecular imaging 42, 197-209, 2015 | 1128 | 2015 |
| The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma … A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ... Journal of clinical oncology 30 (13), 1438-1446, 2012 | 719 | 2012 |
| Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy W Weichert, A Röske, V Gekeler, T Beckers, C Stephan, K Jung, ... British journal of cancer 98 (3), 604-610, 2008 | 582 | 2008 |
| HDAC expression and clinical prognosis in human malignancies W Weichert Cancer letters 280 (2), 168-176, 2009 | 481 | 2009 |
| Fungi and inflammatory bowel diseases: alterations of composition and diversity SJ Ott, T Kühbacher, M Musfeldt, P Rosenstiel, S Hellmig, A Rehman, ... Scandinavian journal of gastroenterology 43 (7), 831-841, 2008 | 478 | 2008 |
| Mass spectrometry–based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors C Denkert, J Budczies, T Kind, W Weichert, P Tablack, J Sehouli, ... Cancer research 66 (22), 10795-10804, 2006 | 474 | 2006 |
| Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo W Weichert, A Röske, S Niesporek, A Noske, AC Buckendahl, M Dietel, ... Clinical Cancer Research 14 (6), 1669-1677, 2008 | 456 | 2008 |
| Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis W Weichert, A Röske, V Gekeler, T Beckers, MPA Ebert, M Pross, M Dietel, ... The lancet oncology 9 (2), 139-148, 2008 | 453 | 2008 |
| Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617: dosimetry estimate and empiric dose finding C Kratochwil, F Bruchertseifer, H Rathke, M Bronzel, C Apostolidis, ... Journal of Nuclear Medicine 58 (10), 1624-1631, 2017 | 413 | 2017 |
| Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas AH Scheel, M Dietel, LC Heukamp, K Jöhrens, T Kirchner, S Reu, ... Modern Pathology 29 (10), 1165-1172, 2016 | 404 | 2016 |
| Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes S Mueller, T Engleitner, R Maresch, M Zukowska, S Lange, ... Nature 554 (7690), 62-68, 2018 | 403 | 2018 |
| Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking J Weischenfeldt, T Dubash, AP Drainas, BR Mardin, Y Chen, AM Stütz, ... Nature genetics 49 (1), 65-74, 2017 | 395 | 2017 |
| Metabolite profiling of human colon carcinoma–deregulation of TCA cycle and amino acid turnover C Denkert, J Budczies, W Weichert, G Wohlgemuth, M Scholz, T Kind, ... Molecular cancer 7, 1-15, 2008 | 394 | 2008 |
| ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival W Weichert, T Knösel, J Bellach, M Dietel, G Kristiansen Journal of clinical pathology 57 (11), 1160-1164, 2004 | 359 | 2004 |
| Distinct types of tumor-initiating cells form human colon cancer tumors and metastases SM Dieter, CR Ball, CM Hoffmann, A Nowrouzi, F Herbst, O Zavidij, ... Cell stem cell 9 (4), 357-365, 2011 | 352 | 2011 |
| Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma C Denkert, KJ Winzer, BM Müller, W Weichert, S Pest, M Köbel, ... Cancer 97 (12), 2978-2987, 2003 | 337 | 2003 |
| CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy CE Engeland, C Grossardt, R Veinalde, S Bossow, D Lutz, JK Kaufmann, ... Molecular Therapy 22 (11), 1949-1959, 2014 | 324 | 2014 |
| Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer A Noske, W Weichert, S Niesporek, A Röske, AC Buckendahl, I Koch, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 303 | 2008 |
